characteristics.text: SAMN44047940
characteristics.characteristic: External Id
characteristics.text: Tianjin Medical University
characteristics.characteristic: INSDC center name
characteristics.text: 2024-10-03T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-10-03T16:16:05.523Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS22807297
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS22807297
characteristics.characteristic: SRA accession
characteristics.text: H2BK120ub
characteristics.characteristic: antibody
characteristics.text: HepG2
characteristics.characteristic: cell line
characteristics.text: human hepatocellular carcinoma cell
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: HepG2
characteristics.characteristic: source_name
characteristics.text: sgUSP22_H2BK120ub_ChIP
characteristics.characteristic: title
characteristics.text: HepG2 cells were infected with lentiviruses expressing cas9 and USP22 sgRNA to establish USP22 knockout cells, followed by treatment with Sorafenib for 24 hours.
characteristics.characteristic: treatment